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A STUDY ON STRESS HYPERGLYCEMIA IN 
MODERATE DEGREE BURNS  
ABSTRACT 
 
BACKGROUND -  Stress hyperglycemia is a transient  event but has its 
own morbidity and mortality. In this study we saw the prevalence of  stress 
hyperglycemia in moderate degree burns  and its impact on patient outcome. 
 
MATERIALS AND METHODS: 150 patients were taken up for 
study.Patients with moderate degree burns 15-30%, age >18 years, non 
diabetics were taken up for study.Patients who  diabetics ,age<18 years, 
gestational diabetes,on steroids were excluded from the study. Patients with 
random blood sugar >200 on admission were seen three days fasting sugar 
and one postprandial sugar.Patients were diagnosed as diabetic according to 
ADA criteria.Patients with hyperglycemia were seen HbA1c to rule out 
stress hyperglycemia and diabetes, since HbA1c showed last three months 
sugar status. 
 
RESULTS: Among 150 patients 133patients were stress hyperglycaemic 17 
were newly detected diabetes .Stress hyperglycaemia caused longer duration 
of stay >15 days,p value (0.009).Males had longer duration of stay,p 
value(0.034) .It was more common  among young females aged less than 30 
years,p value(0.048). More common among younger age group.Non 
pseudomonas organism(staphylococcus, klebsiella, proteus etc ) was the 
most common organism found, p value(0.005). Staphylococcus was the 
common single organism and Staphylococcus and Klebsiella was combined 
organism.The hyperglycaemic sugar range was 200-250mg/dl .Non 
pseudomonas organism was more in younger age group p value (0.005). No 
mortality was seen in stress hyperglycaemic patients. Mortality was seen in  
three patients who were diabetic and they were infected with combined 
organism. 
 
CONCLUSION: Thus from the study we see stress hyperglycemia causes 
increased morbidity in the form of longer duration of stay,infection ,and 
affects younger age group. 17new  diabetic cases  were detected. 

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1. INTRODUCTION 
 
Stress hyperglycemia (stress diabetes or diabetes of injury) is a 
elevation of the blood glucose for any stress in the form of illness. It gets 
corrected spontaneously, but has to be differentiated from various forms of 
diabetes mellitus. Stress hyperglycemia indicates state of insulin secretory 
capacity which is reduced or a reduced sensitivity to the insulin, and is the 
first clue to incipient diabetes.  
 
It occurs in acute stressful state which includes stroke, burns, 
myocardial infarction and any critical illness. It’s due to the over activity 
and over production of counter regulatory hormones.  Burns is a highly 
acute stressful state, caused by heat, electricity, chemicals, light, radiation or 
friction.123  Following the  injury,  there appears to be  varied metabolic 
changes , which includes energy expenditure,  protein break down which is 
elevated,  and alterations in fat metabolism.  
 
Insulin resistance is the major factor for all effects, because more data 
have shown insulin resistance and its association with liver function 
derangement as a cause for increasing the morbidity and mortality which is 
seen in burned patients.456 The metabolism of fat is altered postburn; which 
is related to changes in insulin resistance. The high sugar alters the outcome 
in burns in the form of graft uptake and sepsis. There are few studies 


regarding burns and its hyperglycemia, either due to stress or diabetes. 
Therefore this study aims at finding out hyperglycemia due to stress or 
diabetes in burns and its outcome.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

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2. AIM OF STUDY 
 
1. To find out prevalence of stress    hyperglycemia    in   moderate 
degree burns patients.         
2. To find out stress hyperglycaemic outcome in moderate degree burns 
patients. 
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3. REVIEW OF LITERATURE 
 
The  burns and hyperglycemia  relationship  has been dated back to 
the Viet Nam war.7 Hyperglycemia due to  insulin resistance may occur due 
to elevation   of counter regulatory hormones, inflammatory cytokines, 
intravenous  fluids in the form of dextrose support, and steroid treatment.8 
Even people who were not diabetic can become hyperglycemic and 
approximately 25% of traumatic  patients with no  history of diabetes can 
develop hyperglycemia.910    Stress hyperglycemia in illness is elevation in 
the blood sugar  due to the illness which  is a stress. It corrects  or get 
controlled after the stress but to rule out diabetes . 
 
Most of the burns injury affect only the superficial  skin.Rarely, the 
deeper structures of  muscle, bone, and blood vessels be affected. In the  
patients with burn injury  insulin resistance is what being recognized. 
 
 
 
 
 
 
 
 


3.1 EPIDEMIOLOGY:-  
 
The number of studies regarding stress hyperglycemia is less . 
Umpierrez et al.11showed prevalence of diabetes around 26% in  
hospitalized patients . Among them  12% of  patients were newly diagnosed 
diabetes or stress related hyperglycemia. Levetan et al. 12 showed a 13% 
prevalence of  hyperglycemia in 1,034 consecutively hospital  inpatients. 
Based on hospital chart review, 64% of patients with hyperglycemia were 
known diabetic or were newly detected diabetesin the hospital stay.Thus 
average incidence is 12-13%.Till  2004, 11 million burn injured people were 
seeking  hospital care throughout the world.13  90% of burns occurs in the 
emerging countries   and among them 70% of them were pediatric aged.  
Mortality was more for burns with distribution of  40% of body  area  found  
in the developing countries 14.In India about 700,000 people suffer from  
injury of burns and  getting treated from  hospital, while  very few seek care 
in higher instituitions. 
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3.2 BURNS:-  
A burn is a injury to the body skin and flesh which is caused by heat 
contact, lightening, chemicals, electricity. The part of the body mostly 
affected is the skin dermis and epidermis. In severe burns deeper tissues 
may be affected like muscle and bone .It can also affect the blood vessels 
and can be more painful. It can be treated by simple methods out of hospital 
or can be treated at higher centres. The treatment involves removal of dead 
tissue, wound debridement, skin grafting, antibiotics and fluids. Burns can 
be very fatal but due to modern treatments prognosis is good. 
 
Burns can be classified by the type of injury, depth of injury, extent 
and other co morbid conditions. Burns are classified  according to the depth 
of injury to the skin and are categorized into four degrees. This 
classification was given by French barber-surgeon Ambroise Pare and  till 
date,  it is in use.15 
 
The depth of burn is very difficult to determine. It is more difficult for 
second degree burns since it evolves over time. The difference between 
superficial thickness and partial thickness burns is important for treatment 
because superficial burns heal spontaneously but partial thickness burns 
requires surgical grafting.  


The following tables describe degrees of burn injury  
 
Names 
Layers 
involved 
Appearance Texture Sensation 
Time to 
healing 
First degree Epidermis Redness Dry Pain +  < 1weeks 
 
 
Second 
degree 
 
Extends into 
superficial 
dermis 
Red colour 
blister. 
Moist Pain + 2-3weeks 
Extends into 
deep dermis 
Red and 
white 
blisters. 
Blood + 
Moist Pain + 
Weeks-
may 
progress to 
third 
degree 
Third degree 
(full 
thickness) 
Extends till 
entire dermis 
White or 
Brown 
Dry, 
leathery 
Pain 
absent 
Excision  
Required 
Fourth degree 
Skin, 
subcutaneous 
tissue, 
muscle, bone 
Charred, 
Black, 
Eschar + 
Dry 
Pain 
absent 
Excision  
Required 

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Figure - 1 First and Second Degree Burns 
 
Figure - 2 Second Degree Burns 


 
 
 
Figure- 3, Third-Fourth Degree Burns 
                           

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3.3 CAUSES OF BURNS:- 
There are number of causes of burns. They are chemical,electrical, 
radiation and scalding.   
 
3.3.1 CHEMICAL: -   
Among the chemicals it is caused by  corrosives or  caustic alkalis 16 
The  caustic  compounds includes  sodium hydroxide or silver nitrate, and 
acids such as sulfuric acid[17]  Hydrofluoric acid results in  deep burns and  
sometimes not quickly  evident.[18] Chemical burns can be of any degree, 
depending on the nature of substance.  
 
3.3.2 ELECTRICAL :- 
Electrical burns are due to an electric shock or short circuit. Electrical 
burns most commonly include workplace injuries, domestic current injuries, 
defibrillation, or cardio version without a conductive gel. Though visible 
burn injury may not be seen with electrical burns, it could be fatal due to 
internal injury. It could be due to cardiac arrhythmias. Lightning is also a 
rare cause of electrical burns. It causes cardiac arrest and ventricular 
fibrillation but generates relatively low heat energy deposit into skin, thus 
producing few or no burn marks at all.19 High voltage electricity, causes 
very deep seated wounds. It is common cause for deeper burns due to the  


raised  temperature   and flashes  associated with  the voltages which is 
around  thousand volts. 
 
3.3.3 RADIATION:-    
Radiation burns are caused by prolonged exposure to ultra violet light 
from sun, cancer treatment with radiation,  sun lamps, radioactive fallout 
and X-rays. The most common radiation type of burn is due to sun 
exposure.It is due  to the  ultraviolet light A and B. B light wavelength is 
more dangerous. With more severe sun radiation it  results in  sun poisoning 
or "heatstroke". Tanning booths also cause burn injury. They cause skin 
irritation, reddish discoloration, swelling and inflammation.  Microwave 
burns are caused by the thermal effects of microwave radiation.  
 
3.3.4 SCALDING:-  
Scalding ( meaning hot in latin .20) results from hot substances like 
liquids and gases. A so called immersion scald  occurs when  hands or legs 
are immersed in hot water,  and is the most  common  burn seen in child 
abuse21.  A blister is a  serous fluid filled lesion in the skin.  It occurs as a 
response  to the heat and inflammatory reaction. The top of blister is peeled  
but the fluid has toxic substances. Scald type of  burns are more often seen 
in children. Generally scald burns are first or second degree burns, third 
degree burns can occur when there is   prolonged contact.  


3.4 PATHOPHYSIOLOGY 
3.4.1 BURNS :-   
Burn injury results in a local inflammatory response and in larger 
burns there is a systemic inflammatory response. The lungs are affected due 
to smoke inhalation and venous return from the burned circulation. After  
burns injury,tachycardia  and resistance increase peripherally. This is due to 
the release of epinephrine, nor epinephrine,etc  from injured tissues, and the 
relative decrease  in blood flow due to change in body fluids. Initially heart 
ejection of blood is reduced but after 24hours post burn injuries, ejection   
becomes  normal if treated with adequate fluids. The output later meets the 
metabolic needs of the body. 
 
High degree of heat injury results in various chemical reactions and 
alteration in protein structure. 22 
 
The pain fibres are stimulated due to heat and protein structures are  
altered which  results in damage to body parts. The pain fibres which are 
stimulated release neuropeptides. Activation of complement occurs.  
Immune complex  proteins attract the neutrophils which degranulate to 
release free radicals and proteases causing the damage. Mast cells when 
undergone degranulation releases the tumor necrosis factor – α (TNF – α, 
primary cytokine).  This TNF – α is chemo attractant  to other inflammatory 

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cells, and these inflammatory cells release secondary cytokines.23 These 
cytokines which are secondary increases the permeability of blood vessel in 
burn area. This causes exudation of proteins and fluid into the adjacent 
interstitial tissue. Red cells are not extravasated. As a result, there is 
increase in the oncotic pressure in the interstitium. The volume of fluid loss 
is directly proportional to the area of burn injury. If burn area is 10% to 15% 
of the total body surface area (TBSA) the consequent fluid loss may cause 
circulatory shock. If the area is larger  than 25% of TBSA, infection and 
inflammation of adjacent tissues results in more volume loss.23    
 
3.4.2 STRESS AND HYPERGLYCEMIA:-  
Hyperglycemia due to stress is due to a highly complex interplay of 
counter-regulatory hormones. This includes epinephrine, norepinephrine, 
growth hormone, cortisol, and cytokines.24,25 The cytokine production and 
hormonal derangements may be affected by underlying illness. There exists 
complex mechanism between hormones and inflammatory cells 26 and this 
complex  environment ultimately leads to more liver  glucose synthesis  and 
ineffective action of insulin . More liver production of carbohydrates by 
gluconeogenesis, plays major role in hyperglycaemia.27,28. The increased 
glucagon is the primary mediator of gluconeogenesis,  although it occurs 
with epinephrine29 and cortisol30 which also contribute. Tumour necrosis 

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factor-α (TNFα) also   promotes gluconeogenesis by stimulating the 
glucagon hormone .31 
 
The resistance of insulin is seen as inability to suppress the glucose 
release from liver. In the periphery, insulin resistance occurs by two major 
pathways. The decreased  insulin-mediated uptake  of glucose  occurs 
because of reduced signalling for receptor32and downregulation  of glucose 
transporter (GLUT)-4.33 super added with this , decreased clearance of 
glucose  occurs since glycogen synthesis is affected in skeletal muscle.34 
Both increased  cortisol35and   increased epinephrine36       reduce insulin 
actions . Cytokines such asTNFα37 and intrleukin 138 inhibit post receptor 
signalling of insulin. The consequences of illness results from the reduced 
glucose uptake.  Furthermore, hyperglycaemia increases the cytokine, 
inflammatory, and oxidative stress response, which sets  up a vicious cycle 
whereby raised sugar further increases sugar..39-41There is a insulin 
resistance state which promotes a catabolic state, where lipid lysis takes 
place . The excess fatty acid further causes more insulin resistance. This in 
turn causes more glucotoxicity. Glucotoxicity, lipotoxicity, and 
inflammation occurs, in which are the key components in the exaggerated 
global insulin-resistance syndrome associated with acute form of illness.   It 
also causes endothelial dysfunction, which has relation with insulin 
resistance. Hyper insulin state further increases hormone production and 

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impairs fibrinolysis. There is also glucose uptake due to GLUT 1 
upregulation. It is glucose transporter involved in non insulin mediated 
glucose uptake .Though non oxidative metabolism is impaired oxidative 
metabolism is up regulated. In addition   therapeutic interventions like 
steroids, enteral and parentral nutrition, fluids, catecholamine infusions can 
worsen hyperglycamia. Thus there are no studies comparing the outcome of 
diabetes and stress hyperglycemia and also to see whether the 
pathophysiology is same for both. 
 
The following diagram and flow chart depicts the cause mechanisms in 
stress hyperglycemia 
 
 
 
 
 
 
 
 
Figure - 4 
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GLUCOSE METABOLISM IN STRESS HYPERGLYCEMIA 
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Figure – 5 
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3.4.3 BURNS AND HYPERGLYCEMIA  :- 
The post burns injury,  hyperglycemic response occurs. It results in 
alterations in body metabolism. It causes energy expenditure, increased 
protein break down, and alteration in fat metabolism . There is relationship 
between insulin resistance and fat metabolism post burn trauma. Reduced 
response  to insulin action  is the prime factor , as more datas already 
show,and liver function derangement results in  mortality and morbidity of  
injured patients. There is also link between first 48 hours hyperglycemia and 
mortality. Higher the  glucose  more is the  graft loss. Fat metabolism is also 
altered post burn injury, and this may be related to the resistance to insulin 
which occurs following post burn injury.  
 
Burn patients  also have increase in lipid lysis, inadequate increases in 
the fat  metabolism disproportionate  to energy needs, and  triglycerides 
deposits in distant sites,  in other tissues , which includes skeletal muscle 
and liver.42, 43, Studies show there is different   metabolic  system following a 
burn  injury .45 .The first phase which occurs after 48 hours of injury  is 
called the “ebb phase” 45,46 This  part of the phase  appears to be influenced 
by  the type of the trauma, release of hormones,  which includes 
catecholamines, dopamine, glucagon, and cortisol.47,48,49 In the acute stage of 
hyperglycemia insulin release is suppressed by epinephrine.  
 


 
The amount of  lipid release is variable after trauma. It may be 
increased, not changed, and decreased. The rise in lipids  depends upon the 
nature of adipose tissue before and after injury.  The cycling of free fatty 
acids is increased. This is due to catecholamines acting on hormone 
sensitive lipase to produce lipolysis and also raised lactate concentrations . 
 
The second phase of burn injury after  several weeks of  injury, is 
called the “flow phase.50, 51.  Plasma sugar comes down initially, but is on the 
higher range, and insulin level risesover period of  time marking the state of 
insulin  resistance. Though hormones play a role in insulin resistance, 
hormone  levels  decrease after the initial injury.52,53   
 
Skeletal muscle is the major uptaker of 70–80% of whole body 
glucose by insulin. In burns decrease in  muscle mass following burn injury 
could cause insulin resistance during flow phase . Lipid lysis is also 
increased.  Increased  lipid lysis is due to increase adrenergic activity. It is 
also related to subcutaneous fat. When more fat is lost increased lipolysis 
occurs. Though lipid lysis  is elevated  after burns, the concentration of 
lipids is fluctuating. Glycerol concentrations are elevated in burns.it 
signifies lipid lysis. Once released from adipocyte it cannot be reutilized for 
triglyceride synthesis. It is used as a measure of lipolysis post burn trauma.  


 
Lipids are hydrophobic  and bind to proteins in plasma. In burns 
patients there is  reduced protein levels, this alters the ratio of binding  of 
lipids  to proteins in  burns patients   compared with healthy controls54. 
Intracelullar turnover of FFA depends on the breakdown of muscle and 
adipose tissue triglycerides. This again is reesterified into VLDL and 
incorporated into adipose tissue TG. In burns patients for each turnover, one 
glycerol and three FFA are released. The rate of release does not meet the 
bodies energy demands and in excess  so reesterified as VLDL-TG.     
 
In healthy adults, 65% of VLDL-TG is reesterified and released after 
four days  of hyperglycemia. Thus the free fatty acid cycle is related to 
increased sugar after trauma yet the link not clear. The following flow chart 
depicts the events post trauma. 
 

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The following flow chart depicts the events post trauma – catecholamines 
and cytokines are increased which leads to more delivery of free fatty acid. 
TRAUMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
↑FFA Delivery 
 
Figure - 6 
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P38 MAP - Kinase 
TNF-α 
Free Radicals 
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3.5 INTERACTIONS BETWEEN GLUCOSE AND FAT 
METABOLISM 
The metabolism of  glucose occurs in liver and muscle tissue.  Liver 
and muscle are also involved in the metabolism of fat. This overlapping is to 
be understood.  The interaction in these tissues between glucose and fat 
helps to  understand the physiology in  resistance to insulin actions. Insulin 
resistance depends more on fatty tissue. The liver and muscle metabolism is 
as follows 
 
3.5.1 HEPATIC METABOLISM:-  
Liver is organ of metabolism .It plays a major role in glucose 
metabolism. It produces glucose in fasting state by gluconeogenesis and 
glycogenolysis. After eating  promotes glycogen synthesis .Insulin 
resistance occurs when it fails to reduce blood sugar and lipid lysis. Raised 
sugar   post injury is due  to more glucose synthesis and glycogen break 
down that occur in the liver, which in turn occurs due to release  in 
catecholamines   via various methods55 This occurs with stimulation of 
cAMP which in turn stimulate pyruvate kinase which inhibits glycolysis and 
thereby increase glucose production. 
 
Catecholamines activate  p38  a mitogen-activated protein kinase, 
causing the release of tumour necrosis factor-α (TNF-α) and interleukin-1 

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(IL-1), and stimulate nuclear factor-κB (NF-κB) via IKK 56 Due  to the 
catecholamines, saturated plasma free fatty acid  is elevated, which activates 
NF-κB via toll-like receptor-4 57.  NF-κB can cause cell damage and  liver 
tissue damage  severe injury which is documented.  NF-κB produce  IL-6, 
which can cause increased liver glucose and decreased effect of insulin .58,59  
There are multiple factors involved in increasing the hepatic metabolic rate.  
During second phase of injury, more glucose is produced. There is more 
protein break down, so amino acids are used for gluconeogenesis. This 
hyperglycemia is not suppressed by insulin.   
 
The hepatic glucose output also is not suppressed. This increased 
glucose during this time is responsible for post burn trauma hyperglycemia. 
There is also increased delivery of free fatty acids to the liver. This free fatty 
acid can be reesterified or stored for energy  within hepatocytes as 
triglyceride. Hepatomegaly can occur because of  increased free fatty acid 
and TG storage in liver.  Triglyceride in liver increases mortality. It is also 
responsible for the insulin resistance. Thus both the TG in liver and insulin 
resistance are the mechanism involved in post trauma hyperglycemia. The 
liver actions are shown in following chart: 
 
 
 

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The Liver Metabolism is depicted in the following chart. 
LIVER 
Gluconeogenesis  
Glycogenolysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure - 7 
NF- κβ → IL6
Damage to 
Mitochondria  
↑Hepatic TG  
↑Long Chain Fatty 
Acyl CoA   
↑Malonyl CoA    
Insulin Resistance   
Hyperglycemia    
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3.5.2 MYOCYTE METABOLISM:-  
Muscle is responsible for resistance to insulin in diabetes mellitus 
Glucose transportation occurs  inside the cell via GLUT 4 transporter.  This 
moves to the surface of cell after binding of insulin to insulin receptor. This 
intiates signal cascade which involves insulin signal receptor  
phosphorylation  by tyrosine, association of phosphatidylinositol kinase 3 
with IRS-1, and mobilization of GLUT-4 stores. In diabetes this 
phosphorylation is decreased. The same mechanism occurs following post 
burn. The comparison is shown in Table 1 & 2.  
 
During starvation  the phosphorylation by tyrosine  is decreased 
because of  no insulin  . The resistance   to insulin is found to be due to 
different site of storage of triglycerides  within the myocytes. There is 
increased muscle protein lipase and increased free fatty acid delivery. This 
increase intramyocellular TG and decrease insulin signalling and deceased 
glucose uptake. Studies show   interactions between intracellular lipids 
which incudes   intramyocellular TG, diacylglycerol (DAG), and fatty acyl-
CoA, and insulin sensitivity.60 The metabolic products of fat are thought to 
influence the insulin signalling or increase the protein kinase C(PKC) which 
inactivates IR and IR-1. 
 

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The insulin sensitivity is related to fat. Malonyl co A dehydrogenase 
splits  down malonyl co A and oxidates fat  . Palmitate oxidation also 
increases insulin sensitivity. The intracellular lipids accumulation is due to 
two cardinal  factors, the release of fatty acids and β oxidation of fat  . Beta 
oxidation of fat is increased but not able to meet the energy demands. 
Mitochondria is affected  in multiple tissues by burns.  IN Mitochondria 
oxidative capacity of pyruvate and palmitate is reduced. mitochondrial gene 
expression is also reduced. The mitochondrial dysfunction causes skeletal 
muscle apoptosis. The reason for  mitochondrial damage is not clear in 
burns. It  partly occurs secondary to reactive oxygen species (ROS).   
 
After burns cardiac muscle has large influx of calcium due to 
mitochondrial nitric oxide synthase. The  nitric oxide  damage the 
mitochondrial membrane by blocking the cytochrome c activity. The 
calcium flux also increases phospholipase A2. This in turn  produce free 
fatty acids that alters the membrane  of mitochondria and  activity of 
cytochrome c. Free fatty acids also increase reactive oxygen species. Thus 
increased fatty acids, along with dysfunction of mitochondria, result in more 
lipid deposits intracellularly which in turn reduces the action of insulin  


The Muscle Metabolism is depicted in the following chart. 
MUSCLE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure - 8 
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Table - 1 
Comparison of Cell Signalling in Diabetes and Stress 
Cell Signal 
Diabetes 
Mellitus 
Post Stress
Insulin receptor phosphorylation reduced reduced 
IRS-1 tyrosine phosphorylation reduced reduced 
AKT/PkB association with IRS-1 reduced reduced 
PKC Phosphorylation raised raised 
 
The muscle cell signalling is same in both acute and chronic stress  
 
Table - 2 
Lipid levels in muscle in diabetes mellitus Vs Post Stress 
Lipids 
Diabetes 
Mellitus 
Post Stress
Triglyceride raised raised 
Diacylglyceride raised no change 
Long chain fatty acyl-CoA raised nochange 
 
The intracellular lipid concentrations are not the same in acute and chronic 
stress 
 
 

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3.6 MECHANISM OF ADVERSE OUTCOMES:  
Stress hyperglycaemia which is acute, results in metabolic and 
hormonal dysregulation , than that occurs in  chronic hyperglycaemic state, 
of  diabetes mellitus. It is this dysfunction which needs treatment. For 
example, in the failure of all organs  due to microvascular endothelial 
abnormality , intensive insulin therapy is needed  to protect endothelium.61 
Chronic hyperglycemia also sets a cellular preconditioning which is 
protective in acute hyperglycemia due to stress. This occurs by 
downregulation of glucose transporters in chronic hyperglycemia .GLUT-1 
and GLUT-3 are glucose transporters independent of insulin. They are 
upregulated in acute illness and so glucotoxicity occurs. Various oxidative 
stressors are also involved in upregulation of GLUT-1 in endothelial cells. 
 
The acute variations in glucose concentration during period of stress 
is responsible for  mortality than the mean glucose concentration. These 
fluctuations cause increased endothelial apoptosis, endothelial dysfunction, 
and oxidative stress.  It is the  oxidative injury in  acute hyperglycaemia 
compared to chronic hyperglycemia  that is  responsible for the mechanism 
of adverse effects of stress hyperglycaemia. Also hypoglycaemia can 
increase the adverse effects. Hypoglycaemia per se can increase 
inflammation which is already more in acute state. 
 


The following diagram shows the overall effect of hyperglycemia  
EFFECTS OF HYPERGLYCEMIA 
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3.6.1 HYPERGLYCEMIA AND CARDIAC SYSTEM:- 
Immediate  hyperglycemia produces multiple effects on the heart. It  
affects  the  preconditioning of the hypoperfused heart,  which is  protective  
for  the decreased blood flow  insult62. Additionally , the area of infarction  
is increased  with  hyperglycemia. There is also decreased cardiac blood 
flow . Cardiac myocyte death occurs  through cell death  or by exaggerating 
ischemic blood flow  cellular injury63,64. The other effects  of immediate 
hyperglycemia includes, changes in the blood pressure, elevation in 
catecholamine, abnormalities in the platelets, and electrophysiologic 
changes. Marfella et al, induced sudden rise in blood sugar   (270 mg/dl or 
15 mmol/l) over 2 h in healthy males and found that it elevated  blood 
pressure, pulse rate , rise in  catecholamine levels, and  prolongation of 
QTc65. Some more studies have also shown an   association between sudden 
rise in sugar  and raised viscosity,hypertension  66, and ANP levels. There is 
also increased mortality with hyperglycemia seen in myocardial infarction 
patients.  
 
3.6.2 HYPERGLYCEMIA AND THROMBOSIS:- 
More  analysis  have shown link between hyperglycemia and 
abnormalities in thrombosis. Hyperglycemia induces reduced fibrin lysis   
and  plasminogen of tissue  activity. Inhibition of plasminogen  is 
increased.Thrombaxane biosynthesis is increased, with   reduction in blood 


sugar thrombaxane synthesis is decreased. Hyperglycemia causes increase 
of  (IL)-6 levels elevates   fibrinogen of plasma  and fibrinogen mRNA.67 In 
diabetes patients the  activity of platelets is increased. which is  seen as  the   
attachment  of platelets , on the extracellular matrix . 68 In a analytical  study, 
12 patients were subjected to hyperglycemic (250 mg/dl) and euglycemic 
(100 mg/dl) status.  
 
Raised sugar  causes  activation of platelet  and the expression of 
platelet P-selectin and lysosomal integral membrane protein (LIMP). Raised 
sugar  also increased the plasma clotting  von willebrand factor and urinary 
11-dehydro-thromboxane B2 (corresponds to  thromboxane A2 production). 
Howevere such effects not observed in normoglycemic patients. Thus 
increased  platelet activity can occurs in stressful conditions. 
 
3.6.3 HYPERGLYCEMIA AND INFLAMMATION:- 
Vascular changes occur due to the involvement of inflammatory 
changes. Other studies suggest that increased  IL-6, TNF-α, due to raised 
sugar  produce  acute inflammation.  Antibody against  TNF alpha will 
control the  stimulation of IL-6 by glucose.. The inflammatory response is 
seen in adipose tissue, vascular smooth muscles and other tissue cell types.  
Hyperglycemia causes increase in IL-6, IL-18, TNF alpha.  TNF-α 
causes enlargement  of the necrotic area  in left anterior desending artery 


occlusion. In humans,  the more rise in TNF-α levels  more is the  severity 
of cardiac dysfunction. It  causes some injury to kidney  due to 
hypoperfusion and  to heart also leading to  failure. The preconditioned 
staus  however reduces the post ischaemic myocardial TNF-α production.  
IL-18 causes disruption of  atherosclerotic plaques, which causes acute 
ischemic syndromes. Increase  of these  factors  cause adverse  vascular 
effects .The most common  relation  between inflammation and raised sugar 
level is  due to    pro inflammatory transcriptional factor, nuclear factor 
(NF)-κB by exposure  to different  cell types during  1–8 days of 
hyperglycemia69,70. Nuclear factor (NF)-Κb has its own adverse effects. 
 
3.6.4 HYPERGLYCEMIA AND ENDOTHELIAL CELL 
DYSFUNCTION:-  
Hyperglycemia and poor cardiac outcomes are due to effect of raised 
sugar levels on blood vessel  endothelium. It plays a critical role in 
homeostasis.The bolod  vessel   lining maintains the blood vessel   in a 
relaxed , thrombolytic, antioxidant, and  anti aggregating . During stress, the 
vessel endothelium undergoes dysfunction, nonregulation, and failure. 
There is increased cell to cell attachment  , new vessel cell formation ,  
becomes more permeable , inflammatory  and failure.   Human in vivo 
studies using this data confirm that sudden rise in sugar seen in the  hospital   
causes endothelial dysfunction 71,72 Hyperglycemia directly alters  the  


function of  endothelium by inhibiting nitric oxide .  This is again has been 
linked to increase in the cell to cell adhesion, disturbed new vessel 
formation, increased permeability of the cell, inflammatory changes and pro 
thrombotic state. The  function of endothelium is evaluated by measuring  
vasodilatation effects , on atrey like brachial artery.    Hyperglycemia also 
triggers the output  of reactive oxygen species (ROS) or activates other 
mechanisms. 
 
3.6.5 HYPERGLYCEMIA AND THE BRAIN:- 
Sudden onset hyperglycemia seems to be linked  with increased 
neuronal damage due to brain hypoperfusion.. The major portion of the 
brain that is more prone  to injury from raised sugar  is the ischemic 
penumbra.  It surrounds the ischemic core. During stroke in  progression the 
penumbra becomes  areas of infracted brain  tissue or recover as non 
infracted  tissue. The elevated glucose concentrations is associated with 
increased lactate and tissue acidosis. Lactate has been seen to cause damage 
to the neurons, astrocytes, and endothelial cells of the brain.73-75. Lactate-
choline ratio is seen, which predicts the outcome and also infarct size. More 
recently, some investigators demonstrated a positive link between 
hyperglycemia and  production of lactate  76. Through this mechanism, hyper 
glucose state  causes infarction of brain due to ischemia . Hyperglycemia 


also causes accumulation   in the neocortex with glutamate. Increased 
glutamate levels are perdictors of ensuing damage that occurs to neurons. 
 
It is also seen from studies, that hyperglycemia causes break down   
of DNA, blood-brain barrier alteration, rapid change of polarization in 
penumbral tissue which is severely hypoperfused, β-amyloid precursor 
protein elevation, and increase in superoxide levels in the neuronal    
tissue.77-80  Hydroxyl free radicals are increased in hyperglycemia. They 
cause tissue damage. Elevated glucose levels also cause decreased nitric 
oxide, increase IL-6, m RNA, and decreased cerebral flow. Thus studies 
show the link between hyperglycemia and neuronal injury.  
 
3.6.6 HYPERGLYCEMIA AND OXIDATIVE STRESS:-   
Hyperglycemia also causes oxidative injury in the form, by 
generating more reactive oxygen species (ROS).   The oxidative stress 
occurs when there is imbalance between  production of  ROS and its   
metabolism . Endothelial injury when occurs,  produces super oxide anion  
than nitric oxide.This in turn causes production of secondary mediators , 
growth factors, transcriptional factors.  Thus from direct tissue injury 
or hyperglycemia induced secondary factors   oxidative stress cause tissue 
injury and death. 
 
 


 
3.6.7 HYPERGLYCEMIA AND IMMUNITY:- 
There is relationship between raised glucose levels  and infective 
state.  The major reason   identified is defective phagocyte function . There 
has been funtional alterations in monocyte and neutrophil, including the 
adhering and  chemotactic  mechanism, phagocytic, bacterial killing, and 
respiratory chain . Granulocyte function improves with reduction in blood 
sugar .The adherence of granulocyte is improved.    
 
There has been elevated levels of cytosolic calcium. Increased 
cellular calcium  cause reduction in ATP level and defective phagocytic 
response.. There exists a  link among polymorpho nuclear cellular  calcium 
and fasting sugar level. They are inversely related  to the phagocytosis  of 
cells. Decrease  in the glucose levels results in decreased intracellular  
calcium, increased energy  content, and  effective phagocytosis.  
 
The  microvascular side veffects  of diabetes is due to changes  in 
metabolic pathway. Most of these pathways contribute to immune 
dysfunction. Protein kinase c pathway mediates the neutrophil dysfunctionas 
a result of  hyperglycemia .  It is seen reduced super oxide  formation and 
decreased  activity  of phospholipase D occur with hyperglycemia . 
Impaired  antioxidant  formation has link with  leukocyte dysfunction.   In 
neutrophils also reduced ROS occurs due to hyperglycemia .Hyperglycemia 


also inhibits glucose 6 phosphate dehydrgenase. Aldolase reductase pathway 
is found to cause infections and there is a decrease in infections with 
aldolase reductase inhibitor. In acute hyperglycemia reduction in 
lymphocyte function is also observed. Tcell subsets CD4 and CD8 are also 
decreased. 
 
Finally  studies on  the impact  of hyperglycemia on the immune 
system constantly  show that high glucose content  causes immune 
suppression and immune dysfunction. Control of glucose or reduction of 
glucose improves the immune function. 
 
3.7 MANAGEMENT:-  
Currently there is no separate management for stress hyperglycemia 
and diabetes. However there may be variations in treating ICU and non ICU 
patients. Treatment modality are tried  after  results  of  Nice-Sugar study     
It says that glucose control should not be withheld in intensive care unit, but 
less intensive target should be achieved.81,82. 
 
In the setting of  non intensive care patients  no  data exist to guide 
the  treating plan , but individual treatment according to glucose levels can 
be done.83,84 There are no studies that have specially  studied  the best 
treatment  for the management of stress induced hyperglycemia. It is 
reasonable to follow  methods, for treating admitted  patients  with 


hyperglycaemia, since   acute  hyperglycaemia is a  short duration  event, 
and a dynamic disorder which responds to changes in the disease course. 
The accepted method  for control of sugar is insulin therapy, but in the 
surgical and medical ICU insulin infusions are preferred for treatment. 
There is stacking of insulin and hypoglycemia in edematous patients or 
hypo perfusion with subcutaneous insulin 85.  
 
Subcutaneous dosing of insulin  is ideal for most medical and surgical   
patients who are treated outside intensive care unit . in  the  outpatient  
treatment ,  analogues of insulin  which produce less hypoglycaemia than do 
short and long acting human insulin were preferred, but such evidence was 
not found in any study.86. Results of other studies also show that 
subcutaneous basal bolus insulin was effective than the  titrating units  of 
insulin used  for attaining a safe, effective  sugar  control.  Patients treated 
with insulin infusion in intensive care unit  later changed to subcutaneous 
insulin had better outcomes. The dose of insulin can be adjusted daily, but 
requires couple of days  to reach control of sugar.   Dose adjustment should 
be according to diet intake. .Diet management should also be done in 
hyperglycaemic patients. This strategy includes giving consistent foods rich 
in carbohydrate , or treating with insulin after food according to estimated 
levels of carbohydrate taken by patient during enteral feeding, close 
monitoring is necessary. Insulin can be withheld if it is necessary.  


 
The quantity  of glucose given by fluids  or other modes  is mostly 
not noticed. They may be restricted when necessary.  There is no reliable  
evidence that tells  reduction of  glucose fluctuations, gives better outcomes. 
However, changes in insulin replacement can be done and also to keep 
adequate carbohydrate intake87,88. 
 
Patients with good sugar control require reduction of insulin 
accordingly. Experts don’t practice with the  oral  drugs for most hospital 
inpatients because of its  delayed onset  of action and effects and the 
common side effect of  hypoglycaemia in patients  whose food  intake is 
variable.. The adverse effects of drugs is also contraindication.  
 
Multiple studies suggest the treatment of glucose insulin potassium 
(GIK) infusions for cardiac and neurological benefits 89,90.  Control  of sugar 
is not the aim  of such infusions.  Though  insulin has a  important  role 
directly in the infusion effects ,  other confounding  factors also has effects 
in this therapy. The basis behind such intervention is mismatch  between 
decreased glycolysis product in infracted tissue and increased fatty acids 
levels due to lipid lysis 91. In hypoperfused  heart ,ATP is reduced and 
elevated   inorganic phosphate  levels seen..  ATP is important because it 
maintains the cell membranes, myocardium and its contractility, and 


protects from the adverse recations  of fatty acids, which is found in 
underperfused  myocardium92,93,94. Free fatty acids  cause increased  heart 
activity,more   heart  damage, and conduction disturbances in heart. 
Accordingly, studies in hearts of the rat , have demonstrated the usefulness 
of glucose insulin potassium therapy, in the glycolysis, ATP levels , and the 
levels of phosphate which is inorganic  in the damaged  tissue 95.  
 
In other animal experiments  also this  treatment improved heart 
function and metabolic effects. As a treatment  for patients in  acute stress, 
this  infusion  is associated with decrease in all adverse effects and good 
improvement in  survival. There is less data regarding  usefulness of this 
therapy in strokes or cerebral ischemia only few studies have shown  safety 
of GIK therapy in the acute stroke. Besides GIK therapy, insulin has its 
effect on complications. Insulin is helpful for endothelial cell function.  
Insulin is also  vasodilator  in  arteries. The vasodilatory properties of 
insulin is due to nitric oxide. Endothelial cell cultures of arteries have 
demonstrated there is  nitric oxide synthase action  and raise in levels of  
nitric oxide levels. P-selection is expressed in high glucose levels. Insulin 
therapy also has inflammation reduction  effects. It decreases C-reactive 
protein (CRP) levels in patients.   
 


Microbiological studies have shown that insulin can reduce the free 
radical  stress and cell death  in myocardium.  Insulin also reduces the ROS,  
transcription factor NF-κB, intercellular adhesion molecule (ICAM)-1, and 
the chemokine monocyte chemoattractant protein (MCP). It inhibits the 
production TNF alpha. Insulin also improves lung and heart function .  
There is evidence that insulin is helpful in protecting from  the CNS, renal, 
and lungs ischemia . In   severe burns,  which produce catabolic state raised 
sugar  produces  more muscle catabolism, while  insulin has a  anabolic 
effect . Insulin treatment  also acts as fibrinolytic therapy. Insulin infusion 
decreases the collagen-induced platelet aggregation. Thus in summary it is 
seen that insulin is highly beneficial in hospital hyperglycemia either 
directly or through its effects on lipolysis, glycolysis, etc.  
 
3.8 LINK BETWEEN METABOLIC STRESS, INSULIN, 
HYPERGLYCEMIA AND OUTCOME:  
Thus in summary as already shown by studies, increase in 
counterregularory hormones increase catabolic state, liver gluconeogenesis, 
and lipolysis. These in turn lead to increased sugar,  free fatty acids,  
ketones, and lactate.  Insulin action is blunted due to glucotoxicity which 
leads to further rise in sugar. The low insulin and  raised sugar affects, the 
immune system and function,  metabolic needs of the body,and  produces 


products  which lead to more  tissue damage and organ derangements . Thus 
the combination of high sugar  and low insulin  is responsible for adverse 
effects in stress induced hyperglycemia. 
 
3.9 PREVENTION:  
It is genrally not predictable or preventable to identify hospital related 
hyperglycemia. However, early suspicion and intervention is useful to 
prevent stress hyperglycemia . From studies it is found that preoperative 
glucotoxicity could also affect the treatment of postoperative control for 
sugar. Even intraoperative sugar control is very dangerous for certain 
procedures. The effectiveness of control of sugar depends on the accurate 
glucose monitoring. 
 
In an ICU set up there are various confounding factors which could 
make the measurement inaccurate like anemia, hypotension, because they 
cause capillary readings inaccurate.    It is highly challenging to measure 
glucose in increased severity of illness. Constant checking of sugar will help 
to control sugar levels.Measurement errors can occur. Oral glucose 
tolerance test or close check of sugar  in hyperglycaemic patients is 
necessary.  It is ideal to follow up patients after discharge to see for 
underlying diabetes and to manage appropriately.  
 
 


3.9.1 FUTURE PERSPECTIVES: 
Studies  for comparing the outcome is whether due to  diabetes or  
hyperglycaemia  due to stres are needed.  HbA1c to be checked to 
differentiate between long term  diabetes or stress hyperglycemia, and  to 
diagnose  stress exacerbation in diabetics..   
 
A comparative study  between normal patients having  hyperglycemia 
and with diabetics having  elevation of sugar  due to stress , is needed.  The 
optimum target glucose range which is to be maintained in stress 
hyperglycaemic conditions is still undefined. Studies also say that various 
targets and their risk benefit ratio should be analysed. 
 
Till  data are available, it is difficult to improve and control  sugar 
with insulin regimens and monitor glucose . It will be helpful  for the  risk 
stratification.  
 
Stress hyperglycaemia is thus a heterogeneous entity with unique 
pathophysiological features and complications. It has its own adverse 
effects.  Present concepts   from various studies, tell us that hyperglycaemia 
should be treated irrespective of its cause.  
 
 
 
 
 


 
However, from studies it is seen the duration of hyperglycaemia and 
comorbid  factors, which varies with each  patients or populations seeks  
more attention . Thus stress hyperglycemia needs to be identified early and 
treated, and follow up and monitoring of the patients will provide more data 
regarding the stress hyperglycemia and its effects.  Thus this study is done 
to see stress hyperglycemia in burns patients  and its outcome. 


4. MATERIALS AND METHODS 
 
4.1 Inclusion criteria:-  
A total of 150 patients who were admitted in the burns department in 
kilpauk medical colllege were taken up for present study. Patients with 
moderate degree burns (15-30%) were selected for study. Patients were seen 
random blood sugar, three days fasting sugar and postprandial sugar and 
HbA1c. Patients were diagnosed as DM as per american diabetes 
association criteria.  
 
ADA criteria is as follows:  
a) Fasting plasma glucose>=126mg/dl 
b) 2 Hour plasma glucose>=200mg/dl 
c) Random blood sugar >=200mg/dl 
d) HbA1c>=6.5% 
 
4.2 Exclusion criteria:- 
Since it is study of stress hyperglycemia, patients already known 
diabetics were excluded from study. Severe burns patients were also 
excluded since mortality was high. Females with history of gestational 
diabetes were also excluded. Patients age < 18 years and other co morbid 
conditions, and taking steroids were excluded.   
 


 
4.3 METHODOLOGY: 
Patients with random sugar more than 200mg/dl after admission were 
selected and 3 days fasting and PPBS was taken, if sugar was high, HbA1c 
was done to rule out diabetes from stress hyperglycemia. HbA1c was done 
by biorad method. If patient had diabetes, HbA1c would be higher than 6.5 
(according to ADA criteria) and if it was less than 6.5 then patient is in 
stress hyperglcemia.HbA1c reflects the last three months sugar status so if it 
is high it could not be due to acute stress now. 
 
4.4 STATISTICAL ANALYSIS: 
The statistical analysis used in the study are chi-square test, for 
discrete variables, paired T test for continuous variables, ANOVA (analysis 
of variance) for more than two groups. All the tests were performed using 
SPSS (Statistical package for social sciences) version 17. 
 
 
 
 
 
 


 
5. RESULTS AND OBSERVATIONS 
 
General characteristics:  In the present study a total of 150 patients 
were selected according to inclusion criteria, from the 700-800 patients 
admitted in the burns department with moderate degree burns in one year. 
Diabetes was ruled out from them by seeing HbA1c, and observations made 
subsequently.  The total number of male and female in the study were 72 
and 78. Among them newly detected diabetes were 17 in the study. Since it 
is study about stress hyperglycemia the diabetes were ruled out and the 
remaining 133 patients were taken to study.  The total number of male and 
female with stress hyperglycemia were female 67 and male 66. Among 
them people were grouped into three age groups, those who are < 30 years, 
30-45 years and more than 45 years.  Their duration in hospital was divided 
into lesser duration of 15 days and more than 15 days.  
 


The following observations were made subsequently: 
5.1 SEX AND AGE GROUP:- 
The number of male and female patients in each age group were first 
seen. 
 
SEX AGE GROUP 
 <30 years 30-45years >45 years Total 
Female 40 21 6 67 
% 59.7% 31.3% 9.0% 100.0% 
Male 27 25 14 66 
% 40.9% 37.9% 21.2% 100.0% 
Total 67 46 20 133 
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5.2 SEX AND HOSPITAL DAYS:- 
The sex and hospital days observed is as follows. 
 
SEX Hospital days 
 <15 days >15days Total 
Female 23 44 67 
% 34.3% 65.7% 100.0% 
Male 12 54 66 
% 18.2% 81.8% 100.0% 
Total 35 98 133 
 
In both the sex more number are found in longer duration of stay in 
>15days. In females 44/67 and in males 54/66 are found in longer duration 
of stay. 
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5.3 SEX AND STRESS HYPERGLYCEMIA:- 
 
Sex Stress hyperglycemia  
 <250mg/dl >250mg/dl Total 
Female 56 11 67 
 83.6% 16.4% 100.0% 
Male 49 17 66 
 74.2% 25.8% 100.0% 
Total 105 28 133 
 
From the study it is seen the overall distribution of sex in stress 
hyerglycemia is 67/133 females and 66/133 males. The sugar range for 
stress hyperglycemia was grouped into lesser range of <250mg/dl and 
higher range >250mg/dl.   
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5.4 STRESS HYPERGLYCEMIA AND AGE GROUP:- 
 
 
Comparison between stress hyperglycemia and age group showed 
more number in <250mg/dl sugar around 105/133 and around 28/133 in 
>250mg/dl. 
 
Younger age group <30 years were around 53/105 and had sugar in 
the range of <250mg/dl. 
 
 
 
STRESS 
HYPERGLYCEMIA 
AGE GROUP 
 
<30 years
30-45 
years 
>45 years Total 
<250mg/dl 53 37 15 105 
% 50.5% 35.2% 14.3% 100.0%
>250mg/dl 14 9 5 28 
% 50.0% 32.1% 17.9% 100.0%
Total 67 46 20 133 
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5.5. STRESS HYPERGLYCEMIA AND HOSPITAL DAYS:- 
 
The sugar value was   taken has two group those with sugar <250mg 
and those with sugar >250mg.  The sugar value and hospital days observed 
in the study is as follows:   
 
 
Around 110 patients had sugar <250mg/dl and among them 76/110 
were found in longer duration of stay. More than 250mg/dl  sugar was found 
in 23 patient and among them 22 had longer duration of stay.  
 
 
STRESS HYPERGLYCEMIA  
GROUP 
Hospital days 
 < 15 Days > 15 Days Total 
< 250 mg / dl 34 76 110 
% 30.9% 69.1% 100.0%
> 250 mg / dl 1 22 23 
% 4.3% 95.7% 100.0%
Total 35 98 133 




%
%
%
%
%
%
%
%
&%
$%
%
!"# !"#
#
#
      
CHART – 5 
 
Figure–14 Comparison between Stress Hyperglycemia and Hospital Days 
 
The total patient with sugar value less than 250 were 110/133 , and 
among them 76 had longer duration of stay which accounts for 69.1%  and 
more than 250 were  totally 23/133 and among them 22 had longer duration 
of stay which is 95.7%.  The chi square - 6.921 and p value - 0.009 which 
was statistically significant.  


5.6 STRESS HYPERGLYCEMIA AND ORGANISM :- 
The organism groups was divided into three. Pseudomonas, non 
pseudomonas, and no growth. Non pseudomonas organism included 
staphylococcus, proteus, klebsiella, E.coli. Acinetobacter, coccobacillus, 
and combined organisms.   
  
ORGANISM GROUP STRESS HYPERGLYCEMIA 
 
< 250 mg/ dl > 250 mg/ dl Total 
pseudomonas 9 9 18 
% 50.0% 50.0% 100.0% 
Non pseudomonas 90 18 108 
% 83.3% 16.7% 100.0% 
No growth 6 1 7 
% 85.7% 14.3% 100.0% 
Total 105 28 133 
  
Non pseudomonas organisms were more around 108/133 which is 
81.2%. No organism was found in 7/133. It is seen that non pseudomonas 
organism were also high in lesser sugar range 90/105 with sugar less than 
250mg/dl. 
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5.7 ORGANISMS IN STRESS HYPERGLYCEMIA:- 
 
The total number of organism for the whole 150 patients were 
studied. It was seen there was only one acinetobacter, coccobacillus, and 
Ecoli infection. Klebsiella was found in 17, proteus-11, pseudomonas-17, 
staphylococcus-52. Combined infection klebsiella and pseudomonas-4, 
klebsiella and proteus-11, klebsiella and staphylococcus-15, klebsiella and 
acenatobacter-1. Proteus and staphylococcus-10, and pseudomonas and 
staphylococcus-2. 
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Figure–16 Total Number of Single Organisms 
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The following chart tells the total no of combined organisms 
 
 
 
Figure–17 Total Number of Combined Organisms 
 
The combined organisms infection was more with klebsiella and 
staphylococcus. 
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5.8 AGE AND HOSPITAL DAYS:- 
 
DAYS AGE GROUP 
Years < 30 Years 30 -45 Years > 45 Years Total 
< 15 Days 17 15 3 35 
% 48.6% 42.9% 8.6% 100.0%
> 15 Days 50 31 17 98 
% 51.0% 31.6% 17.3% 100.0%
Total 67 46 20 133 
  
The analysis between the hospital days and age group showed more 
number in longer duration of stay 98/133 as compared to lesser duration 
which was 35/133. 
 
The longer duration of stay was found higher among younger age 
groups which is less than 30 years of age around50/67 which is around 
74.62%. 
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5.9. ORGANISM AND HOSPITAL DAYS:-  
As already seen organisms observed in the study were grouped into 
three pseudomonas, non pseudomonas which includes other organisms like 
(staphylo coccus, proteus ,klebsiella etc  and combined organisms) and no 
growth. The comparison between organisms and duration of stay is as 
follows. 
 
 
 
 
 
 
 
 
 
 
 
 
Non pseudomonas organism 74.1% had longer duration of stay. It 
was not statistically significant. No growth of any organism was found in 
three patients who had longer duration of stay. 
ORGANISM  GROUP Hospital days 
 < 15 Days > 15 Days Total 
Pseudomonas 3 15 18 
% 16.7% 83.3% 100.0%
Non-  Pseudomonas 28 80 108 
% 25.9% 74.1% 100.0%
No Growth 4 3 7 
% 57.1% 42.9% 100.0%
Total 35 98 133 
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5.10 ORGANISM AND MORTALITY:- 
 
From the study only three mortality was found. The three was in 
diabetic group. Analysis was done for the total 150 patients. The mortality 
was see in combined organism group. It was seen in pseudomonas and 
klebsiella group and staphylococcus and pseudomonas group. 
 
Pseudomonas and klebsiella was found among two and 
staphylococcus and pseudomonas was found in one patients who died. All 
patient were diabetic.  
 
 
 
 
 
 
 
 
 
 


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Figure–20 Comparison between Organisms and Mortality  
 
The above chart show that mortality was found among combined 
organism than single organism. Staphylococcus infection is seen in more 
number of patients 52/150. 
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5.11. MORTALITY AND HOSPITAL DAYS:-  
Since only 3 deaths and all three were diabetic, mortality and hospital 
days was seen for all the 150 patients.  It was observed longer duration of 
stay was not associated with mortality. 
 
Among the 3 who died 2/3 had shorter duration of stay and only one 
had longer duration of stay. It was not statistically significant.  
 
 
OUT COME DAYS GROUP 
 
<15 days >15 days Total 
Alive 35 112 147 
% 23.8% 76.2% 100.0% 
Death 2 1 3 
% 66.7% 33.3% 100.0% 
Total 37 113 150 
/2


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5.12 ORGANISMS AND AGE GROUP:-  
    
ORGANISM 
GROUP 
AGE GROUP 
 
<30years 30-45years >45 years Total 
pseudomonas 6 5 7 18 
% 33.3% 27.8% 38.9% 100.0%
Non pseudomonas 57 38 13 108 
% 52.8% 35.2% 12.0% 100.0%
No growth 4 3 0 7 
% 57.1% 42.9% .0% 100.0%
Total 67 46 20 133 
                                                                                                                          
As seen non pseudomonas organism were more and among them 
younger individuals had infection more with non pseudomonas organisms. 
Infection is always found in older age group. There was no older age 
without organism infection.  
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5.1.1 CORRELATION: 
Using bivariate correlation, correlations seen in the study. The 
average burns % observed was in the range of 23%in all the three age group. 
There was no significant correlation between height, weight, sugar, Hba1c, 
and age group in the study. 
 
Descriptive Statistics 
    
 Mean Std. Deviation N 
AGE 33.28 13.646 133 
PR 86.70 12.630 133 
HEIGHT 158.00 4.616 133 
WEIGHT 59.50 7.844 133 
%BURNS 23.53 5.113 133 
RBS 227.48 33.382 133 
FBS-D1 166.29 32.504 133 
FBS-D2 152.63 24.806 133 
FBS-D3 141.64 24.261 132 
HBA1C% 5.47 .574 133 
DAYS 19.71 7.418 133 


6. DISCUSSION 
 
The analysis of stress hyperglycemia in 150 burns patients  and its 
outcome was done in this study .They were analysed with respect to age, 
sex, percentage of burns, duration of stay, recovery or death,  organism 
found  and urine acetone. Since the treatment was varying for each patient 
and there was no protocol for treatment it could not be seen. Urine acetone 
was negative for all in the study. In this study out of total 150 patients 72 
were males and 78 were females. Out of the 150 patients 17 were diagnosed 
as diabetes with HbA1c.  
 
Among the 150 patients 133 were with stress hyperglycemia, which is 
around 88.6% in this study. This is comparable to previous studies, but 
incidence there was around 27% and  12% respectively 11 12   however in the 
previous studies the number of people involved was large  which could 
attribute to lower incidence and also did not differentiate between diabetes 
and stress hyperglycemia. There are rarely any studies that distinguish 
between stress and diabetes induced hyperglycemia using HbA1c.  
 
 
 
 
 
 
 


6.1 STRESS HYPERGLYCEMIA AND SEX:- 
From the study it was seen females and males were more or less 
equal. Among the 133 patients  67 were female and 66 were male. Females 
were one number higher than males.  
 
6.2 STRESS HYPERGLYCEMIA AND AGE GROUP:- 
In the study patients were grouped into three age groups as already 
seen. Stress hyperglycaemic sugar was also seen for < 250 mg and > 250 
mg. Age group <30 years were more in the study and they had sugar in the 
range of 200- 250mg.  This shows stress hyperglycemia was more for 
younger age group as compared to older age. Inspite of co morbid 
conditions in older age, stress hyperglycemia has been found in younger age 
group in this study possibly due to more accidental burn injury seen in 
younger patients. There was however no statistical significance between 
stress hyperglycemia and age group. 
 
6.3 STRESS HYPERGLYCEMIA AND HOSPITAL DAYS:- 
From the study we see there are more number of patients with longer 
duration of stay among the stress hyperglycemia. From the figure-14, 69.1% 
with sugar < 250 are having longer duration of stay but, the number of 
people with more than > 250 sugar range  are less, but among them 95.7% 
are having longer duration of stay. This shows stress hyperglycemia 


increases the duration of stay probably due to tress hyperglycaemic  effects 
on healing and other factors. The average   duration of stay observed in the 
study is around 19.71 days. It is similar to previous study Silmara et al 
which shows longer duration of stay in hyperglycemia and mean days 
around 15.5 days.  
 
6.4 STRESS HYPERGLYCEMIA AND ORGANISMS:-  
Pseudomonas is most common organism among burns patients and so 
patients were taken as three groups for analytical purpose. Other organisms 
staphylococcus, proteus, klebsiella, acinetobacter, combined organism 
infection were   taken as one group and no growth the other group. Non 
pseudomonas organisms as a group were high among the stress 
hyperglycemia. Thus in stress hyperglycemia non pseudomonas organisms 
are high, and this is statistically significant. Non pseudomonas infection 
people had sugar in the less than 250 mg range. It shows lesser sugar is also 
associated with more organisms. 
 
The total number of organism found in study shows more was seen 
with staphylococcus around 52. Among combined organism more number 
was seen with klebsiella and staphylococcus around 15. The organism was 
seen for all the 150 patients. This shows from study common organism in 
high sugar is staphylococcus. 


 
6.5 STRESS HYPERGYCEMIA AND MORTALITY:- 
In this study group only 3 patients had died, and they were also 
diabetic newly detected. So burns with diabetes which is a more septic 
condition, would also have been the cause for death. Among stress 
hyperglycaemic patients there was no death seen in this study. This is 
because in the study more younger age had stress hyperglycemia, than older 
age group. Mortality increases with age, so younger age group were able to 
withstand the adverse effects. 
 
From the study we see that females were more compared to males and 
among them more females were in the younger age group.  In the older age 
group more males were found .young females are more prone to burns than 
males, could be a reason for more young females.  
 
The duration of stay with respect to sex was higher among males 
around 81.8% as shown in figure-11, compared to females. The organism 
commonly found includes mixed organisms ie non pseudomonas organism 
which from the study was found to be higher in younger age group <30 
years which is around 51%. In the study it is also found that older age group 
were not without organism. No growth was zero in the older age group 
which tells us that older age are more prone to infection.    
 


6.6 AGE AND HOSPITAL DAYS:-   
From the study there were more patients with longer duration of stay 
and this was also high among younger individuals.  In the study using 
bivariate correlation, it was observed there was no significant correlation 
between variables pulse rate, height, weight, age, percentage of burns, 
random blood sugar, fasting blood sugar, HbA1c and day’s .The average 
age was around 33. The average duration of stay 19.71 days. The average 
percentage of burns observed was 23%.  The average range of HbA1c 
was around 5.47. Random blood sugar was in the range of 227 and fasting 
blood sugars in the range of 140-160. 
 
 
 
 
 
 
 
 
 
 
 

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7. CONCLUSION 
 
 The stress hyperglycaemic patients observed in this study are 133/150 
which is around 88.6%.  
 Newly detected diabetes from the study are 17 with 11.3% incidence.  
 The sugar range for stress hyperglycemia was between 200- 250 mg. 
 The stress hyperglycaemic patients have longer duration of stay. 
 Males with stress hyperglycemia had longer duration of stay. 
 The Stress hyperglycaemia is higher among younger age group which 
is less than 30 years.  
 Stress hyperglycemia is more among young females compared to 
males. 52% females had stress hyperglycemia.  
 Stress hyperglycemia  showed non pseudomonas organisms more.   
 Non pseudomonas organism more in younger age group.  
 Non pseudomonas organisms in stress hyperglycemia was found in the 
sugar range <250 mg / dl. 
 Non pseudomonas organisms showed longer duration of stay.  
 The common single organism found in the study is staphylococcus.  
 The common combined organism found in the study is klebsiella and 
staphylococcus  
 Mortality was found in diabetic patients with combined organism 
infection. 
 No Mortality in stress hyperglycemia. 


 
 
8. LIMITATIONS OF STUDY 
 
1. The number patients taken for study should be more. 
 
2. Long term follow up of patient with stress hyperglycemia to be seen to 
find out how many of them develop diabetes.  
 
3. The effect of modality of treatment for stress hyperglycemia to be 
studied. 


 
 
 
9. RECOMMENDATIONS  
 
 Study to be done   comparing outcomes in stress hyperglycemia and 
diabetes patients. 
 
 Stress hyperglycemia in all stressful conditions to be compared to 
see which causes more hyperglycemia. 
 
 HbA1c in stress hyperglycemia and diabetes patients can be studied 
to see any cut of value is present.        
 
 
 
 
 
 
 
 
 
 


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ABBREVIATIONS 
 
FFA  - Free fatty acid 
TNF α - Tumour necrosis factor alpha 
IL-1  - Interleukin 1 
VLDL - Very low density lipoprotein 
TG  - Triglyceride 
LIMP  - Lysosomal integrated membrane protein  
NF κB - Nuclear factor kappa B   
ANP  - Atrial natriuretic peptide 
DAG  - Diacylglycerol 
PKC  - Protein kinase C 
IKK  - Inhibitor of kappa B kinase enzyme 
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PROFORMA FOR STUDY ON STRESS 
HYPERGLYCEMIA IN MODERATE DEGREE BURNS 
 
S.No :      Date : 
Name :      Age : 
Sex :       IP No:  
D.O.Admission     D.O.Discharge 
 
Degree of burns 
Body Surface Area Burnt 
Area % TBSA Depth 
Head & Neck   
Anterior Trunk   
Posterior Trunk   
Upper Limbs   
Lower Limbs   
Gluteal region   
Perineum   
TOTAL    
 
           


Past h/o: 
Personal h/o: 
Family h/o: 
General examination: 
 Height :    Weight : 
   CVS : 
   RS : 
   P/A : 
   CNS : 
 BP :    PR : 
 
INVESTIGATIONS : 
Blood sugar (R) : 
Fasting blood sugar : 
Day 1 Day 1 Day 3 
   
 
Post prandial blood sugar  : 
Urine Acetone   : 
HbA1c    : 
Blood urea    : 


Serum creatinine   :       
Serum electrolytes   : 
Hb      : 
Others    :  
 
DIAGNOSIS :     
1. Burns 
- Degree 
- Percentage  
2. Stress Hyperglycemia 
3. Diabetes Mellitus 
 
OUT COME : 
1. Recovery/Death 
2. No.of days hospital stay 
3. Infections – Type – Organism  
4. Ketones 
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